The non-hormonal contraceptive is in its first phase of testing with 16 participants in the UK.
RELATED: UC Berkeley researchers developing first unisex, hormone-free birth control
It was developed in conjunction with San Francisco-based startup "YourChoice Therapeutics."
The drug showed high efficacy in early studies. It works by blocking sperm production.
This new trial will test safety, tolerability and the functioning of oral doses.